More intelligence articles

Empowering patients empowers results

Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials

Virtual congresses: video thrilled the cardio tsar

Chris Ross explores the key learnings from a year of virtual congresses

Understand, identify and partner with HCPs to improve patient support

Patients are on the minds of HCPs, and at the forefront is engagement with disease awareness events

Now that COVID-19 vaccines have been approved, it’s our turn, healthcare communicators

The more people who are protected against COVID-19, the better it will be for the health of our global community

Assessing the impact of disease prevalence on access and pricing of rare disease drugs in England

Comparison of orphan drug assessments from NICE versus the NHS

Setting up for success in a post-Brexit, post-pandemic Britain

Creating a new biotech affiliate and seeking marketing authorisation for a new drug in the UK during a pandemic

A new era for UK-Japanese scientific research relations

Japan’s biopharmaceutical firms contributed $62.4bn, or 1.3% of GDP, to the country’s economic output in 2019

New thinking, bold action: building a better future for people living with severe diseases

How UCB Neurology’s deep understanding of people living with neurological conditions is transforming the patient journey

Mapping the patient journey: eight ways to improve support programmes

Chris Ross examines how pharma can drive awareness and adoption of patient support solutions

A cultural shift in clinical research

Research organisations across the board are experimenting with new technologies

Building meaningful customer engagement through data-driven digital insights

Understanding the helpful insights that online HCP conversations can reveal

Integrating competitive intelligence into business development, licensing and M&A strategy

The advantages of partnering with a competitive intelligence or knowledge management team

Reaching patients and HCPs during the pandemic

COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels

Back to the future

Five years ago, an influential book used Darwin’s ideas to predict the future of the industry – how did that work out?

The promise of precision medicine

Precision medicine is set to revolutionise patient care